Today: 16 April 2026
Xero share price rebounds again after tech rout as investors brace for key week
10 February 2026
2 mins read

Xero share price rebounds again after tech rout as investors brace for key week

Sydney, Feb 10, 2026, 17:08 AEDT — The market has wrapped up for the day.

  • Xero shares gained 2.2% by the close, marking a two-day bounce for software stocks that had been under pressure.
  • Tech stocks have found firmer footing after last week’s AI-fueled rout; now, attention shifts to macro data.
  • All eyes now turn to Xero’s May 14 results update, as traders hunt for more clarity on its U.S. performance.

Xero Ltd ended Tuesday at A$84.76, up 2.2%, notching a second day in the green after last week’s heavy tech rout in Australia. The shares changed hands anywhere from A$82.40 to A$85.63.

Xero tends to come up whenever traders talk shifting risk appetite in Australia’s growth space. The S&P/ASX 200 Tech Index just logged a 5.4% gain across two sessions, though it’s still down 7.8% for the week—data from MarketIndex underscores just how tentative this rebound remains.

Overnight, U.S. tech shares bounced back, getting a lift after what Reuters called an AI-driven selloff. Some investors stepped in, looking for bargains before crucial U.S. economic numbers hit. “You’ve a sharply oversold market where a little bit of good news can go a long way,” said Keith Lerner, chief investment officer at Truist Advisory Services, in comments to Reuters. Reuters

Not much movement across the broader local market. The ASX 200 edged down 0.03%, settling at 8,867.4, despite trading higher for most of the session, the ABC Markets live blog reported. CSL was in focus too, after the company announced its chief executive will exit the role on Wednesday, just before half-year results drop.

Just a week back, Xero delivered its latest update, with an investor briefing zeroed in on artificial intelligence and how U.S. payments are tracking. CEO Sukhinder Singh Cassidy told investors the team remains “deeply focused” on what she called the “global AI and US accounting plus payments” play — that’s the total addressable market, or TAM, in industry jargon. The company flagged its next significant update will drop on May 14 with FY26 results, promising more insight into Melio and the state of U.S. operations. ASX filing (PDF)

Xero has managed two days in the green, but the stock remains well under where it stood earlier this year and is currently sitting about 57% below its 52-week high, according to public market data. That steep drop has left shares quick to react to any hint that AI-driven software is changing small business spending — and what those businesses will actually shell out for it.

Next session, traders will be looking to see if the sector bounce has legs once volume picks up, and if attention sticks with earnings—not just the latest AI disruption stories. In Australia, reporting season heats up through the week, and that can send sentiment swinging fast between growth and defensive names.

There’s still a chance the rebound fizzles out—a classic dead-cat bounce. If U.S. inflation data comes in above forecasts, or bond yields spike, high-multiple software stocks could take another hit. And if there are signs that small businesses are pulling back on spending, subscription-heavy models would probably feel it before the rest.

Stock Market Today

  • Kimco Realty's Series D Preferred Shares Yield Exceeds 6%
    April 15, 2026, 7:46 PM EDT. Kimco Realty Corp's 7.25% Series D Cumulative Convertible Preferred Shares (KIM.PRN) traded yielding above 6% on Wednesday, dropping to as low as $59.90. This yield is derived from its quarterly dividend, annualized to $3.6248. The preferred shares are priced at a 21.08% premium over liquidation preference, contrasting with the average 14.38% discount in the real estate preferred stock sector. KIM.PRN yields less than the average 8.11% for real estate preferred stocks but remain notable due to their convertibility with a ratio of 3.4699. On the day, the preferred shares declined about 0.7%, while Kimco's common shares fell 0.5%. The convertible feature allows preferred shareholders to exchange shares for common stock, potentially benefiting from price appreciation.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 10.02.2026

SGX stock price today: Singapore Exchange shares edge up after January trading surge
Next Story

SGX stock price today: Singapore Exchange shares edge up after January trading surge

Go toTop